Alternative Antibody - Enzyme Conjugates for High Sensitivity/specificity immunodetection fostering room temperature stability via excipient stabilized lyophilization

Chipcare技术是一个便携式诊断平台，能够在远程设置中进行快速、准确的临床测试。该平台包括一个紧凑的诊断测试读取器和分析系统，该系统带有装有测试试剂的可互换墨盒。Seneca正在致力于一个项目，以提高墨盒某些部件的保质期，这将使ChipCare能够为服务不足的社区开发新的测试。该项目的成功完成将使ChipCare能够提供新的诊断测试，使公司能够继续扩展到新的市场并实现增长。通过扩大他们的产品供应，ChipCare将创造新的就业机会，并在国际舞台上确立ChipCare和加拿大作为偏远地区护理点测试提供商的地位。除了扩大内部团队，ChipCare预计将增加他们与加拿大分包商的原型和制造努力，从而产生诱导和间接的经济影响。此外，ChipCare可以提供的测试将使加拿大的偏远社区受益，包括难以获得实验室测试服务的北部和原住民社区--该项目将扩大该公司进入这些社区的范围。**

The Chipcare technology is a portable diagnostic platform enabling fast, accurate clinical tests in remote settings. The platform includes a compact diagnostic test reader and analysis system with interchangeable cartridges containing test reagents. Seneca is working on a project to enhance the shelf-life of certain components of the cartridges, which will allow ChipCare to develop new tests for underserved communities. Successful completion of this project will enable ChipCare to provide new diagnostic tests, allowing the company to continue to expand into new markets and grow. By expanding their product offering, ChipCare will create new jobs and establish ChipCare and Canada on the international stage as a provider of point of care tests for remote locations. In addition to internal team expansion, ChipCare anticipates increasing their prototyping and manufacturing efforts with Canadian subcontractors, resulting in induced and indirect economic impacts. Further, the tests ChipCare can offer will benefit remote communities in Canada, including northern and first nations communities, where laboratory testing services are difficult to access - this project will broaden the company's reach into these communities.**